RECURRENT CANCER
Clinical trials for RECURRENT CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental 'T cell Engager' takes on Hard-to-Treat cancers
Disease control OngoingThis early-phase trial is testing a new drug called IMA401, which helps the body's immune T cells attack cancer cells that have certain markers (MAGE-A4 or MAGE-A8). The study includes about 95 adults with advanced solid tumors that have come back or not responded to other treatm…
Matched conditions: RECURRENT CANCER
Phase: PHASE1 • Sponsor: Immatics Biotechnologies GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New targeted drug shows promise for tough ovarian cancer
Disease control OngoingThis phase 2 trial tests a drug called CYH33 in 93 women with recurrent ovarian, fallopian tube, or peritoneal clear cell carcinoma that has a specific genetic change (PIK3CA mutation). The drug works by blocking a protein that helps cancer grow. The main goal is to see if it shr…
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Nanoparticle-Proton combo for recurrent cancer trial pulled before start
Disease control TerminatedThis study aimed to test whether combining special nanoparticles with proton radiation could help control cancers that return after previous radiation treatment. The trial was planned for adults with tumors in specific areas like the skull base or throat. However, the study was w…
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 26, 2026 18:46 UTC